H. Çelik and E. Arinç, “Bioreduction of Idarubicin and Formation of ROS Responsible for DNA Cleavage by NADPH-Cytochrome P450 Reductase and its Potential Role in the Antitumor Effect”, J Pharm Pharm Sci, vol. 11, no. 4, pp. 68–82, Jan. 2009.